Federal Register / Vol. 82, No. 167 / Wednesday, August 30, 2017 / Notices 41267 

questionnaires and provide samples for 

laboratory testing. 

Researchers will follow all studyparticipating mothers’ newborns every 

other week from birth to 6 months of 

age. At all visits, infants will receive 

national recommended clinical care (at 

birth and follow-up visits at 1, 2, and 6 

months), provide samples for laboratory 

testing, and mothers will complete 

study-specific questionnaires about 

infant ZIKV symptoms and 

developmental milestones. During 

follow-up, infants will also have cranial 

ultrasounds, their head circumference 

measured, and hearing and vision tests. 

For mothers and their infants, 

researchers will abstract relevant 

clinical care information from medical 

records. 

The revised information collection 

package includes the following changes. 

During the data collection period, 

researchers will follow a subset of 300 

infants until 2-years of age. These 

infants will have answer questionnaires 

at 6, 12, 18, and 24 months, as well as 

have other clinical assessments 

performed to exam developmental 

delays. 

Researchers will use the study results 

use to guide recommendations made by 

both INS and CDC to prevent ZIKV 

infection; to improve counseling of 

patients about risks to themselves, their 

pregnancies, their partners, and their 

infants; and to help agencies prepare to 

provide services to affected children 

and families. Participation in this study 

is voluntary and there are no costs to 

participants other than their time. 

ESTIMATED ANNUALIZED BURDEN HOURS

Respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total burden 

hours 

Pregnant women ................... Pregnant women eligibility questionnaire ....

Pregnant women enrollment questionnaire

Adult symptoms questionnaire .....................

Pregnant women follow-up questionnaire ....

Infant symptoms questionnaire ....................

3,125 

2,500 

2,500 

2,500 

2,250 

1 

1 

15 

8 

14 

5/60 

35/60 

10/60 

15/60 

10/60 

260 

1,458 

6,250 

5,000 

5,250 

Ages and Stages Questionnaire: 2, 4, 6 

Month.

Ages and Stages Questionnaire: 12, 18, 24 

Month.

Center for Epidemiologic Studies Depression—10.

2,250 

300 

300 

2 

3 

3 

15/60 

15/60 

5/60 

1,125 

225 

75 

Male partners ........................ Male partner eligibility questionnaire ...........

Male enrollment questionnaire .....................

Adult symptoms questionnaire .....................

2,500 

625 

625 

1 

1 

7 

5/60 

25/60 

10/60 

208 

260 

729 

Total ............................... ....................................................................... ........................ ........................ ........................ 20,840 

Leroy A. Richardson, 

Chief, Information Collection Review Office, 

Office of Scientific Integrity, Office of the 

Associate Director for Science, Office of the 

Director, Centers for Disease Control and 

Prevention. 

[FR Doc. 2017–18405 Filed 8–29–17; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30Day–17–0004] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

The Centers for Disease Control and 

Prevention (CDC) has submitted the 

following information collection request 

to the Office of Management and Budget 

(OMB) for review and approval in 

accordance with the Paperwork 

Reduction Act of 1995. The notice for 

the proposed information collection is 

published to obtain comments from the 

public and affected agencies. 

Written comments and suggestions 

from the public and affected agencies 

concerning the proposed collection of 

information are encouraged. Your 

comments should address any of the 

following: (a) Evaluate whether the 

proposed collection of information is 

necessary for the proper performance of 

the functions of the agency, including 

whether the information will have 

practical utility; (b) Evaluate the 

accuracy of the agencies estimate of the 

burden of the proposed collection of 

information, including the validity of 

the methodology and assumptions used; 

(c) Enhance the quality, utility, and 

clarity of the information to be 

collected; (d) Minimize the burden of 

the collection of information on those 

who are to respond, including through 

the use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submission of 

responses; and (e) Assess information 

collection costs. 

To request additional information on 

the proposed project or to obtain a copy 

of the information collection plan and 

instruments, call (404) 639–7570 or 

send an email to omb@cdc.gov. Written 

comments and/or suggestions regarding 

the items contained in this notice 

should be directed to the Attention: 

CDC Desk Officer, Office of Management 

and Budget, Washington, DC 20503 or 

by fax to (202) 395–5806. Written 

comments should be received within 30 

days of this notice. 

Proposed Project 

National Disease Surveillance 

Program II. Disease Summaries (OMB 

Control Number 0920–0004, Expires 

10/31/2017)—Revision—National 

Center for Immunization and 

Respiratory Diseases, Centers for 

Disease Control and Prevention (CDC). 

Background and Brief Description 

CDC requests a three-year approval for 

the proposed revision of the ‘‘National 

Disease Surveillance Program II. Disease 

Summaries’’ information collection 

project. 

As with the previous approval, these 

data are essential for measuring trends 

in diseases, evaluating the effectiveness 

of current preventive strategies, and 

determining the need to modify current 

preventive measures. 

mstockstill on DSK30JT082PROD with NOTICES

41268 Federal Register / Vol. 82, No. 167 / Wednesday, August 30, 2017 / Notices 

Diseases included in this surveillance 

program are Influenza Virus, 

Caliciviruses, Respiratory and Enteric 

Viruses, Foodborne Outbreaks, 

Waterborne Outbreaks and 

Enteroviruses. 

Proposed revisions include form 

consolidation, minor revised language 

and rewording to improve clarity and 

readability of the data collection forms 

and the discontinuation of multiple 

previously approved influenza 

collection instruments, and the National 

Respiratory & Enteric Virus Surveillance 

System (NREVSS) Laboratory 

Assessment (CDC 55.83). CDC also 

requests the use of a new form, Suspect 

Respiratory Virus Patient Form, to assist 

health departments and clinical sites 

when they submit specimens to the CDC 

lab for viral pathogen identification. The 

data will enable rapid detection and 

characterization of outbreaks of known 

pathogens, as well as potential newly 

emerging viral pathogens. 

The frequency of response for each 

form will depend on the disease and 

surveillance need. This represents a 

7,116 burden hour reduction since last 

approval. This reduction in burden 

hours is attributed primarily to the 

discontinuation of previously approved 

forms and formatting changes to existing 

forms. The total time burden estimate 

for all collection instruments in this 

revision request is 24,805. 

There are no costs to the respondents 

other than their time. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondent Form name Number of 

respondents 

Number of 

responses per 

respondent 

Avg. burden 

per response 

(in hours) 

Epidemiologist ............ NORS Foodborne Disease Transmission_Person to Person Disease 

Transmission_Animal Contact_Environmental Contamination_Unknown Transmission Mode_52.13.

54 37 20/60 

Epidemiologist ............ WHO COLLABORATING CENTER FOR INFLUENZA Influenza 

Virus Surveillance.

53 52 10/60 

Epidemiologist ............ U.S. WHO Collaborating Laboratories Influenza Testing Methods 

Assessment.

113 1 10/60 

Epidemiologist ............ US Outpatient Influenza-like Illness Surveillance Network (ILINet) 

Weekly_CDC 55.20.

1,800 52 10/60 

Epidemiologist ............ US Outpatient Influenza-like Illness Surveillance Network (ILINet) 

Workfolder 55.20E.

1800 1 5/60 

Epidemiologist ............ Influenza-Associated Pediatric Mortality Case Report Form .............. 57 2 30/60 

Epidemiologist ............ Human Infection with Novel Influenza A Virus Case Report Form .... 57 2 30/60 

Epidemiologist ............ Human Infection with Novel Influenza A Virus Severe Outcomes ..... 57 1 90/60 

Epidemiologist ............ Novel Influenza A Virus Case Screening Form .................................. 57 1 15/60 

Epidemiologist ............ Antiviral Resistant Influenza Infection Case Report Form .................. 57 3 30/60 

Epidemiologist ............ National Respiratory & Enteric Virus Surveillance System 

(NREVSS) (55.83A, B, D) (electronic).

550 52 15/60 

Epidemiologist ............ National Enterovirus Surveillance Report: (CDC 55.9) (electronic) .... 20 12 15/60 

Epidemiologist ............ National Adenovirus Type Reporting System (NATRS) ..................... 13 4 15/60 

Epidemiologist ............ Middle East Respiratory Syndrome (MERS) Patient Under Investigation (PUI) Short Form.57 3 25/60 

Epidemiologist ............ Viral Gastroenteritis Outbreak Submission Form ................................ 20 5 5/60 

Epidemiologist ............ NORS Waterborne Disease Transmission Form_52.12 ..................... 59 1 20/60 

Epidemiologist ............ Influenza Virus (Electronic, Year Round), PHLIP_HL7 messaging 

Data Elements.

57 52 5/60 

Epidemiologist ............ Influenza virus (electronic, year round) (PHIN–MS) ........................... 3 52 5/60 

Epidemiologist ............ Suspect Respiratory Virus Patient Form ............................................. 10 5 30/60 

Leroy A. Richardson, 

Chief, Information Collection Review Office, 

Office of Scientific Integrity, Office of the 

Associate Director for Science, Office of the 

Director, Centers for Disease Control and 

Prevention. 

[FR Doc. 2017–18407 Filed 8–29–17; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifier CMS–10239] 

Agency Information Collection 

Activities: Submission for OMB 

Review; Comment Request 

AGENCY: Centers for Medicare & 

Medicaid Services, HHS. 

ACTION: Notice. 

SUMMARY: The Centers for Medicare & 

Medicaid Services (CMS) is announcing 

an opportunity for the public to 

comment on CMS’ intention to collect 

information from the public. Under the 

Paperwork Reduction Act of 1995 

(PRA), federal agencies are required to 

publish notice in the Federal Register 

concerning each proposed collection of 

information, including each proposed 

extension or reinstatement of an existing 

collection of information, and to allow 

a second opportunity for public 

comment on the notice. Interested 

persons are invited to send comments 

regarding the burden estimate or any 

other aspect of this collection of 

information, including the necessity and 

utility of the proposed information 

collection for the proper performance of 

the agency’s functions, the accuracy of 

the estimated burden, ways to enhance 

the quality, utility, and clarity of the 

information to be collected; and the use 

of automated collection techniques or 

other forms of information technology to 

minimize the information collection 

burden. 

mstockstill on DSK30JT082PROD with NOTICES